Cutting Edge MarinBio Science Newsletter

Looking for a partner with 30 years of proven expertise in taking drugs from development to validation and FDA approval?
Contact us @ 415.883.8000

Marin Biologic Laboratories official logo, representing their expertise in custom assay development and FDA registered contract laboratory services.

Breakthroughs in Antibody-Drug Conjugates (ADCs) Highlighted from ASCO 2024 Abstracts

Introduction An Antibody-Drug Conjugate (ADC) is a precision cancer therapy that harnesses the specificity of a monoclonal antibody to target cancer cells linking it to a potent cytotoxic drug via a chemical linker. This targeted design enables the antibody to selectively bind to cancer cells delivering the drug payload directly to the tumor site while….

Recent Articles